• 1
    Wieling W, Cortelli P, Mathias CJ. Treating neurogenic orthostatic hypotension. In: AppenzellerO, ed. Handbook of clinical neurology: The autonomic nervous system. Part II. Dysfunction. Amsterdam: Elsevier Science; 2000. Vol 75 (31) pp 713729.
  • 2
    Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs and Aging 2001; 18: 495505.
  • 3
    Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470.
  • 4
    Mathias CJ. Autonomic diseases: clinical features and laboratory evaluation. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74 (Suppl. 3): iii31iii41.
  • 5
    Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendations 2004. European Journal of Neurology 2004; 11: 577581.
  • 6
    Lahrmann H, Magnifico F, Haensch CA, Cortelli P. Autonomic nervous system laboratories: a European survey. European Journal of Neurology 2005; 12: 375379.
  • 7
    Mathias CJ, Bannister R. Investigation of autonomic disorders. In: MathiasCJ, BannisterR, eds. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford: Oxford Univ. Press, 2002: 169195.
  • 8
    Ravits JM. AAEM minimonograph #48: autonomic nervous system testing. Muscle and Nerve 1997; 20: 919937.
  • 9
    Chandler MP, Mathias CJ. Haemodynamic responses during head-up tilt and tilt reversal in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy. Journal of Neurology 2002; 249: 542548.
  • 10
    Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. European Heart Journal 2001; 22: 12561306.
  • 11
    Mathias CJ, Fosbraey P, Da Costa DF, Thornley A, Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. British Medical Journal (Clinical Research Ed.) 1986; 293: 353354.
  • 12
    Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA. Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clinic Proceedings 1996; 71: 847853.
  • 13
    Smit AA, Hardjowijono MA, Wieling W. Are portable folding chairs useful to combat orthostatic hypotension? Annals of Neurology 1997; 42: 975978.
  • 14
    Ten Harkel AD, Van Lieshout JJ, Wieling W. Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure. Clinical Science (London) 1994; 87: 553558.
  • 15
    Van Dijk N, De Bruin IGJM, Gisolf J, et al. Hemodynamic effects of legcrossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. Journal of Applied Physiology 2005; 98: 584590.
  • 16
    Wieling W, Van Lieshout JJ, Van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clinical Autonomic Research 1993; 3: 5765.
  • 17
    Smit AA, Wieling W, Opfer-Gehrking TL, Emmerik-Levelt HM, Low PA. Patients’ choice of portable folding chairs to reduce symptoms of orthostatic hypotension. Clinical Autonomic Research 1999; 9: 341344.
  • 18
    Denq JC, Opfer-Gehrking TL, Giuliani M, et al. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clinical Autonomic Research 1997; 7: 321326.
  • 19
    Tanaka H, Yamaguchi H, Tamai H. Treatment of orthostatic intolerance with inflatable abdominal band. Lancet 1997; 349: 175.
  • 20
    Van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clinical Autonomic Research 2000; 10: 3542.
  • 21
    Mathias CJ, Young TM. Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome. European Journal of Neurology 2004; 11: 613619.
  • 22
    Sahul ZH, Trusty JM, Erickson M, Low PA, Shen WK. Pacing does not improve hypotension in patients with severe orthostatic hypotension–a prospective randomized cross-over pilot study. Clinical Autonomic Research 2004; 14: 255258.
  • 23
    Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 1975; 24: 381384.
  • 24
    Hoehn MM. Levodopa-induced postural hypotension. Treatment with fludrocortisone. Archives of Neurology 1975; 32: 5051.
  • 25
    Schatz IJ, Miller MJ, Frame B. Corticosteroids in the management of orthostatic hypotension. Cardiology 1976; 61 (Suppl. 1): 280289.
  • 26
    Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51: 120124.
  • 27
    Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. American Journal of Medicine 1993; 95: 3848.
  • 28
    Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 1997; 277: 10461051.
  • 29
    Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. American Journal of Medicine 1995; 99: 604610.
  • 30
    Schrage WG, Eisenach JH, Dinenno FA, et al. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. Journal of Applied Physiology 2004; 97: 19781984.
  • 31
    Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988; 38: 951956.
  • 32
    McClellan KJ, Wiseman LR, Wilde MI. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. Drugs and Aging 1998; 12: 7686.
  • 33
    Akizawa T, Koshikawa S, Iida N, et al. Clinical effects of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Nephron 2002; 90: 384390.
  • 34
    Iida N, Koshikawa S, Akizawa T, et al. Effects of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. American Journal of Nephrology 2002; 22: 338346.
  • 35
    Carvalho MJ, Van Den Meiracker AH, Boomsma F, et al. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3, 4-dihydroxyphenylserine. Journal of the Autonomic Nervous System 1997; 62: 6371.
  • 36
    Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999; 53: 21512157.
  • 37
    Kaufmann H, Saadia D, Voustianiouk A, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 2003; 108: 724728.
  • 38
    Mathias CJ, Senard JM, Braune S, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clinical Autonomic Research 2001; 11: 235242.
  • 39
    Alam M, Smith G, Bleasdale-Barr K, Pavitt DV, Mathias CJ. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. Journal of Hypertension 1995; 13: 16641669.
  • 40
    Bordet R, Benhadjali J, Libersa C, Destee A. Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration. Clinical Neuropharmacology 1994; 17: 380383.
  • 41
    Bordet R, Benhadjali J, Destee A, Belabbas A, Libersa C. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clinical Neuropharmacology 1995; 18: 8389.
  • 42
    Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. Journal of Clinical Endocrinology and Metabolism 1998; 83: 339343.
  • 43
    Jordan J, Shannon JR, Biaggioni I, et al. Contrasting actions of pressor agents in severe autonomic failure. American Journal of Medicine 1998; 105: 116124.
  • 44
    Conte JJ, Fournie GJ, Maurette MH. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted). Cardiology 1976; 61 (Suppl. 1): 342349.
  • 45
    Lubke KO. A controlled study with dihydergot on patients with orthostatic dysregulation. Cardiology 1976; 61 (Suppl. 1): 333341.
  • 46
    Victor RG, Talman WT. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. American Journal of Medicine 2002; 112: 361368.
  • 47
    Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. New England Journal of Medicine 1993; 329: 611615.
  • 48
    Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Annals of Internal Medicine 1994; 121: 181186.
  • 49
    Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clinical Autonomic Research 1995; 5: 211213.
  • 50
    Kochar MS, Itskovitz HD. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978; 1: 10111014.